Literature DB >> 15338494

Dyslipoproteinemia in patients with active rheumatoid arthritis: effects of disease activity, sex, and menopausal status on lipid profiles.

Wan-Hee Yoo1.   

Abstract

OBJECTIVE: To investigate the lipid profiles in patients with active rheumatoid arthritis (RA) and to assess the relationship of inflammatory disease activity markers, sex, and menopausal status with lipid profiles.
METHODS: Three groups of patients with active RA (n = 184) were studied: men (n = 61, mean age 50.8 +/- 4.81 yrs), premenopausal women (n = 58, mean age 39.2 +/- 2.44 yrs), and postmenopausal women (n = 65, mean age 60.4 +/- 2.14 yrs), and healthy controls (n = 161): men (n = 65, mean age 50.9 +/- 3.42 yrs), premenopausal women (n = 47, mean age 40.3 +/- 1.66 yrs), and postmenopausal women (n = 49, mean age 61.3 +/- 3.16 yrs). We measured fasting plasma levels of total cholesterol (TC), triglyceride (TG), HDL-cholesterol (HDL-C), LDL-cholesterol (LDL-C), lipoprotein (a) [LP(a)], apolipoprotein A1 (apo A1), apolipoprotein B (apo B), and erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP).
RESULTS: Male RA patients had significantly higher apo B/apo A1 and LP(a) and lower HDL-C than male controls. Female RA patients had significantly higher TC, LDL-C, and LP(a) than female controls. Premenopausal RA patients had significantly higher LDL-C, TC/HDL-C, LDL-C/HDL-C, and apo B/apo A1 and lower TG and HDL-C than premenopausal controls. Postmenopausal RA women had significantly higher TG and LP(a) and lower TC than postmenopausal controls. Female RA patients had higher HDL-C, apo A1, and TC/HDL-C and lower apo B/apo A1 than male RA patients. Postmenopausal RA patients had significantly higher TC, TG, TC/HDL-C, apo B, LP(a), and LDL-C/HDL-C than premenopausal RA patients. CRP correlated positively with TC/HDL-C, LDL-C/HDL-C, and apo B/apo A1 and negatively with HDL-C in male RA patients. In female RA patients CRP had positive correlation with TC/HDL-C and LDL-C/HDL-C and negative correlation with HDL-C.
CONCLUSION: These findings suggest that patients with active RA have altered lipid profiles and that disease activity, sex, and menopausal status affect lipid profiles, and these would be expected to change the pattern of atherosclerotic events in RA.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15338494

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  20 in total

Review 1.  Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm.

Authors:  Jamie Robertson; Mike J Peters; Iain B McInnes; Naveed Sattar
Journal:  Nat Rev Rheumatol       Date:  2013-06-18       Impact factor: 20.543

2.  Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion.

Authors:  Inge A M van den Oever; Alper M van Sijl; Michael T Nurmohamed
Journal:  Ther Adv Musculoskelet Dis       Date:  2013-08       Impact factor: 5.346

3.  Ethnicity may be a reason for lipid changes and high Lp(a) levels in rheumatoid arthritis.

Authors:  Mustafa Cesur; Zeynep Ozbalkan; Mehtap Akcil Temel; Yaşar Karaarslan
Journal:  Clin Rheumatol       Date:  2006-05-06       Impact factor: 2.980

Review 4.  Lipid paradox in rheumatoid arthritis: changes with rheumatoid arthritis therapies.

Authors:  Matxalen Amezaga Urruela; Maria E Suarez-Almazor
Journal:  Curr Rheumatol Rep       Date:  2012-10       Impact factor: 4.592

Review 5.  Prevention of Stroke in Rheumatoid Arthritis.

Authors:  Alicia M Zha; Mario Di Napoli; Réza Behrouz
Journal:  Curr Neurol Neurosci Rep       Date:  2015-12       Impact factor: 5.081

Review 6.  A systematic review of the effect of TNF-alpha antagonists on lipid profiles in patients with rheumatoid arthritis.

Authors:  Eduardo Nicolas Pollono; Maria A Lopez-Olivo; Juan Antonio Martinez Lopez; Maria E Suarez-Almazor
Journal:  Clin Rheumatol       Date:  2010-04-10       Impact factor: 2.980

7.  Abnormal lipid metabolism in a rat model of arthritis: one possible pathway.

Authors:  Niraj Kumar Srivastava; Shikha Sharma; Neeraj Sinha; Sudhir Kumar Mandal; Deepak Sharma
Journal:  Mol Cell Biochem       Date:  2018-02-21       Impact factor: 3.396

8.  Impact of treatment with TNF antagonists on total cholesterol in patients with ankylosing spondylitis and psoriatic arthritis.

Authors:  Jose Ramon Maneiro; Alejandro Souto; Juan J Gomez-Reino
Journal:  Clin Rheumatol       Date:  2017-01-20       Impact factor: 2.980

9.  Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritis.

Authors:  M J L Peters; M Vis; V P van Halm; G J Wolbink; A E Voskuyl; W F Lems; B A C Dijkmans; J W R Twisk; M H M T de Koning; R J van de Stadt; M T Nurmohamed
Journal:  Ann Rheum Dis       Date:  2007-02-21       Impact factor: 19.103

10.  Metabolic syndrome in rheumatoid arthritis.

Authors:  Manole Cojocaru; Inimioara Mihaela Cojocaru; Isabela Silosi; Camelia Doina Vrabie
Journal:  Maedica (Buchar)       Date:  2012-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.